Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 12, 2023

BUY
$2.46 - $3.14 $6.26 Million - $7.99 Million
2,543,006 New
2,543,006 $6.33 Million
Q2 2023

Aug 08, 2023

SELL
$2.46 - $3.14 $446,991 - $570,550
-181,704 Reduced 6.67%
2,543,006 $6.33 Million
Q1 2023

Dec 12, 2023

BUY
$2.57 - $8.16 $7 Million - $22.2 Million
2,723,902 New
2,723,902 $7.3 Million
Q1 2023

May 01, 2023

SELL
$2.57 - $8.16 $217,766 - $691,429
-84,734 Reduced 3.02%
2,724,710 $7.3 Million
Q4 2022

Feb 03, 2023

SELL
$5.19 - $13.5 $653,358 - $1.7 Million
-125,888 Reduced 4.29%
2,809,444 $15.3 Million
Q3 2022

Nov 08, 2022

BUY
$5.17 - $16.99 $3.24 Million - $10.6 Million
626,777 Added 27.15%
2,935,332 $36.7 Million
Q2 2022

Aug 09, 2022

SELL
$4.04 - $8.51 $10,435 - $21,981
-2,583 Reduced 0.11%
2,308,555 $11.4 Million
Q1 2022

May 05, 2022

BUY
$7.6 - $11.02 $327,286 - $474,565
43,064 Added 1.9%
2,311,138 $17.6 Million
Q4 2021

Feb 02, 2022

BUY
$10.16 - $16.17 $5.38 Million - $8.57 Million
529,863 Added 30.48%
2,268,074 $23.2 Million
Q3 2021

Oct 26, 2021

BUY
$13.16 - $22.47 $10.8 Million - $18.5 Million
823,373 Added 90.0%
1,738,211 $23.3 Million
Q2 2021

Jul 27, 2021

BUY
$19.57 - $26.32 $17.9 Million - $24.1 Million
914,838 New
914,838 $20.1 Million

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.